Enhanced Survival Prediction in Colorectal Cancer via Multimodal Deep Learning

Overview

The PRISM-CRC deep learning framework integrates histopathology, radiology, endoscopy, and clinical data to improve colorectal cancer prognosis. It achieved a concordance index of 0.82 for 5-year disease-free survival prediction and an AUC of 0.91 for microsatellite instability status, outperforming single-modality models.

Background

Colorectal cancer (CRC) is a leading cause of cancer morbidity and mortality worldwide, with over 1.9 million new cases and 935,000 deaths reported in 2020. Early detection and accurate prognostication remain challenging due to limitations in manual polyp identification and costly molecular testing. Advances in artificial intelligence, particularly deep learning, have shown promise in automating tumor detection and predicting molecular phenotypes from routine clinical data. Integrating multiple data modalities through AI offers a comprehensive approach to improve diagnosis, prognosis, and personalized treatment strategies in CRC.

Data Highlights

Key Findings

• PRISM-CRC integrates histopathology, radiology, endoscopy, and clinical data for CRC prognosis.
• The model achieved a high concordance index (0.82) for predicting 5-year disease-free survival.
• It demonstrated strong performance in identifying MSI status with an AUC of 0.91.
• Multimodal integration significantly outperformed models using single data types.
• The PRISM-CRC risk score provides more granular risk stratification than traditional TNM staging.
• Identifies high-risk Stage II patients who may benefit from adjuvant chemotherapy.

Clinical Implications

The PRISM-CRC framework offers a powerful tool for personalized risk stratification in colorectal cancer, potentially guiding treatment decisions such as the use of adjuvant chemotherapy in high-risk patients. Its ability to integrate diverse clinical and imaging data can enhance diagnostic accuracy and prognostic precision beyond current standards. However, prospective validation is needed to confirm its utility in routine clinical practice.

Conclusion

PRISM-CRC represents a significant advancement in colorectal cancer prognosis by leveraging multimodal deep learning to improve survival prediction and molecular status identification. This approach holds promise for enhancing personalized oncology care through more precise risk assessment.

References

1. Global Cancer Statistics 2020 -- Colorectal Cancer Incidence and Mortality
2. Singh et al. -- KRASFormer: Transformer-based KRAS Mutation Prediction in CRC
3. Li et al. -- Long-MIL: Hybrid Transformer for Whole Slide Images
4. AI-based MSI Testing Approved 2022 -- Rapid Pre-screening of Microsatellite Instability